![]() Phoenix Nest Phoenix Nest is a biotech company that provides treatment for the disease Sanfilippo syndrome. | ![]() Chinook Therapeutics Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases. | ![]() Dr Lal PathLabs Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests. | ![]() Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. | |
Founding Date | Founding Date 2012 | Founding Date 2011 | Founding Date 1949 | Founding Date 2004 |
Type | Type Private | Type Subsidiary | Type Public | Type Public |
Tags | ||||
Locations | Locations New York, US HQ | Locations Seattle, US HQ | Locations Gurugram, IN HQ | Locations Melbourne, AU HQ Singapore, SG New York, US |
Employees | Employees 10 | Employees 27 | Employees 4,099 | Employees 73 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $6.1m (FY, 2022) | Revenue (est.) ₹27.6b (FY, 2026) | Revenue (est.) $17.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹5.3b (FY, 2026) | Cost of goods $1.2m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ₹23.3b (FY, 2026) | Gross profit $16.1m (FY, 2025) |
Net income | Net income N/A | Net income ($187.9m) (FY, 2022) | Net income ₹5.1b (FY, 2026) | Net income ($102.1m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 171m | Total funding raised N/A | Total funding raised $ 56.2m |

Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases.
View company
Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests.
View company
Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View company